Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure

NCT02078947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2021-11-12

No results posted yet for this study

Summary

Aim of the clinical multicenter study (OptimEx-CLIN) is to assess the optimal exercise intervention in patients with Heart Failure with preserved Ejection Fraction (HFpEF; also termed diastolic heart failure) that will best improve peak oxygen uptake (Peak Vo2) and additionally diastolic function (assessed echocardiographically). The investigators hypothesize that exercise training reverses HFpEF and that intensity of exercise training is more important than duration.

Conditions

Interventions

BEHAVIORAL

High Intensity Exercise

BEHAVIORAL

Moderate Continuous Exercise

BEHAVIORAL

Usual Care

Sponsors & Collaborators

  • European Commission

    collaborator OTHER
  • University of Leipzig

    collaborator OTHER
  • University Hospital, Antwerp

    collaborator OTHER
  • Medical University of Graz

    collaborator OTHER
  • Norwegian University of Science and Technology

    collaborator OTHER
  • Charite University, Berlin, Germany

    collaborator OTHER
  • Technical University of Munich

    lead OTHER

Principal Investigators

  • Martin Halle, M.D. · Technische Universität München, Munich, Germany

  • Martin Halle, M.D. · Technische Universität München, Munich, Germany

  • Burkert Pieske, M.D. · Charite University, Berlin, Germany

  • Christiaan Vrints, M.D. · Antwerp University Hospital, Belgium

  • Volker Adams, Ph.D. · Heart Center Leipzig, Leipzig, Germany

  • Ulrik Wisløff, Ph.D. · Norwegian University of Science and Technology, Trondheim, Norway

  • Axel Linke, M.D. · Heart Center Leipzig, Leipzig, Germany

  • Frank Edelmann, M.D. · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-28
Primary Completion
2017-09-30
Completion
2018-06-27

Countries

  • Belgium
  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02078947 on ClinicalTrials.gov